Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eosin is a fluorescent red dye, chemically classified as a brominated derivative of fluorescein, that is widely utilized both as a diagnostic histological stain and as a topical therapeutic agent. In clinical dermatology, aqueous eosin (typically at a 2% concentration) is employed for its astringent and drying properties to treat exudative (weeping) skin conditions, including diaper dermatitis (diaper rash), intertrigo, and certain forms of psoriasis. It functions by non-specifically precipitating surface proteins to dry lesions and provides a mild antiseptic effect that helps prevent secondary bacterial or fungal infections. While it has a long history of use in various pharmaceutical and cosmetic formulations, some modern products, such as those developed by Cooperation Pharmaceutique Francaise, are regulated as medical devices under the European Medical Device Regulation (MDR).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on eosin.